Posters Overview
After administration, ADCs can exist in various forms in the body, including intact ADCs, biotransformation products, free payloads, linker-payload conjugates, and related metabolites. Pharmacokinetic studies of ADCs typically require the assessment of total antibodies, conjugated antibodies, free payloads, drug-to-antibody ratios (DAR), conjugated payloads, drug linkers, relevant metabolites, and the immunogenicity of the ADCs. A variety of bioanalytical platforms are needed to understand the actual role of ADCs in disease, including ELISA, LC-HRMS, and LC-MS/MS.
Complete the form to view and download this poster.
Stay Connected
Keep up with the latest news and insights.